129 related articles for article (PubMed ID: 26488807)
1. Activation of Protein Kinase A in Mature Osteoblasts Promotes a Major Bone Anabolic Response.
Tascau L; Gardner T; Anan H; Yongpravat C; Cardozo CP; Bauman WA; Lee FY; Oh DS; Tawfeek HA
Endocrinology; 2016 Jan; 157(1):112-26. PubMed ID: 26488807
[TBL] [Abstract][Full Text] [Related]
2. Constitutive protein kinase A activity in osteocytes and late osteoblasts produces an anabolic effect on bone.
Kao RS; Abbott MJ; Louie A; O'Carroll D; Lu W; Nissenson R
Bone; 2013 Aug; 55(2):277-87. PubMed ID: 23583750
[TBL] [Abstract][Full Text] [Related]
3. Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage.
Dela Cruz A; Mattocks M; Sugamori KS; Grynpas MD; Mitchell J
Bone; 2014 Feb; 59():211-22. PubMed ID: 24308950
[TBL] [Abstract][Full Text] [Related]
4. Osteoblast AMP-Activated Protein Kinase Regulates Postnatal Skeletal Development in Male Mice.
Kanazawa I; Takeno A; Tanaka KI; Notsu M; Sugimoto T
Endocrinology; 2018 Feb; 159(2):597-608. PubMed ID: 29126229
[TBL] [Abstract][Full Text] [Related]
5. Conditional Deletion of Prolyl Hydroxylase Domain-Containing Protein 2 (Phd2) Gene Reveals Its Essential Role in Chondrocyte Function and Endochondral Bone Formation.
Cheng S; Xing W; Pourteymoor S; Schulte J; Mohan S
Endocrinology; 2016 Jan; 157(1):127-40. PubMed ID: 26562260
[TBL] [Abstract][Full Text] [Related]
6. The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone.
Nakatani T; Chen T; Johnson J; Westendorf JJ; Partridge NC
J Bone Miner Res; 2018 Jul; 33(7):1362-1375. PubMed ID: 29544022
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of TIMP-1 in osteoblasts increases the anabolic response to PTH.
Merciris D; Schiltz C; Legoupil N; Marty-Morieux C; de Vernejoul MC; Geoffroy V
Bone; 2007 Jan; 40(1):75-83. PubMed ID: 16949899
[TBL] [Abstract][Full Text] [Related]
8. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
9. Blockade of receptor-activated G(i) signaling in osteoblasts in vivo leads to site-specific increases in cortical and cancellous bone formation.
Millard SM; Louie AM; Wattanachanya L; Wronski TJ; Conklin BR; Nissenson RA
J Bone Miner Res; 2011 Apr; 26(4):822-32. PubMed ID: 20939063
[TBL] [Abstract][Full Text] [Related]
10. Osteocyte- and late osteoblast-derived NOTUM reduces cortical bone mass in mice.
Nilsson KH; Henning P; El Shahawy M; Wu J; Koskela A; Tuukkanen J; Perret C; Lerner UH; Ohlsson C; Movérare-Skrtic S
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E967-E975. PubMed ID: 33749332
[TBL] [Abstract][Full Text] [Related]
11. Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass.
Goh BC; Singhal V; Herrera AJ; Tomlinson RE; Kim S; Faugere MC; Germain-Lee EL; Clemens TL; Lee SJ; DiGirolamo DJ
J Biol Chem; 2017 Aug; 292(33):13809-13822. PubMed ID: 28659341
[TBL] [Abstract][Full Text] [Related]
12. Activation of Nfatc2 in osteoblasts causes osteopenia.
Zanotti S; Canalis E
J Cell Physiol; 2015 Jul; 230(7):1689-95. PubMed ID: 25573264
[TBL] [Abstract][Full Text] [Related]
13. [Regulation of hypoxia inducible factor-1alpha on osteoblast function in osteogenesis].
Liu XD; Deng LF; Wang J; Qi J; Zhou Q; Wang JS; Wei L; Zhu YP
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3357-61. PubMed ID: 18478952
[TBL] [Abstract][Full Text] [Related]
14. Twist1 Inactivation in Dmp1-Expressing Cells Increases Bone Mass but Does Not Affect the Anabolic Response to Sclerostin Neutralization.
Lewis KJ; Choi RB; Pemberton EZ; Bullock WA; Firulli AB; Robling AG
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505764
[TBL] [Abstract][Full Text] [Related]
15. Osteoblast-specific targeting of soluble colony-stimulating factor-1 increases cortical bone thickness in mice.
Abboud SL; Ghosh-Choudhury N; Liu LC; Shen V; Woodruff K
J Bone Miner Res; 2003 Aug; 18(8):1386-94. PubMed ID: 12929928
[TBL] [Abstract][Full Text] [Related]
16. Increased Bone Turnover and Possible Accelerated Fracture Healing in a Murine Model With an Increased Circulating C-Type Natriuretic Peptide.
Kondo E; Yasoda A; Fujii T; Nakao K; Yamashita Y; Ueda-Sakane Y; Kanamoto N; Miura M; Arai H; Mukoyama M; Inagaki N; Nakao K
Endocrinology; 2015 Jul; 156(7):2518-29. PubMed ID: 25860030
[TBL] [Abstract][Full Text] [Related]
17. Osteoblast-specific Angiopoietin 1 overexpression increases bone mass.
Suzuki T; Miyamoto T; Fujita N; Ninomiya K; Iwasaki R; Toyama Y; Suda T
Biochem Biophys Res Commun; 2007 Nov; 362(4):1019-25. PubMed ID: 17825261
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways.
Baldock PA; Allison S; McDonald MM; Sainsbury A; Enriquez RF; Little DG; Eisman JA; Gardiner EM; Herzog H
J Bone Miner Res; 2006 Oct; 21(10):1600-7. PubMed ID: 16995815
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the Progesterone Receptor in Mx1+ Cells Potentiates Osteogenesis in Calvaria but Not in Long Bone.
Zhong ZA; Sun W; Chen H; Zhang H; Lane NE; Yao W
PLoS One; 2015; 10(10):e0139490. PubMed ID: 26431032
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone injections improve bone quality in a mouse model of osteogenesis imperfecta.
King D; Jarjoura D; McEwen HA; Askew MJ
J Bone Miner Res; 2005 Jun; 20(6):987-93. PubMed ID: 15883639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
